ABSTRACTLung cancer, of which non‐small cell lung cancer (NSCLC) comprises the majority, is the leading cause of cancer‐related deaths in the United States and worldwide. Lung adenocarcinomas are a major subtype of NSCLCs, are increasing in incidence globally in both males and females and smokers and non‐smokers and are the cause for almost 50% of deaths attributable to lung cancer. Lung adenocarcinoma is a tumor with complex biology that we have recently started to understand with the advent of various histological, transcriptomic, genomic and proteomic technologies. However, the histological and molecular pathogenesis of this malignancy is still largely unknown. This review will describe advances in the molecular pathology of lung adenocarcinoma with emphasis on genomics and DNA al...
MedWorm Sponsor Message: Please support the DoctorsInChains.org campaign for the health workers in Bahrain. #FreeDoctors